Background illustration for clinical trials search

Paid Clinical Trials Billings

Discover 125 paid clinical trials in Billings, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

for
Advanced Lung Non-Squamous Non-Small Cell Carcinoma,
Location: Billings MT, Bozeman MT, Great Falls MT, Anaconda MT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04181060

Phase3, Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

for
Lung Non-Small Cell Carcinoma
Location: Billings MT, Bozeman MT, Great Falls MT, Anaconda MT,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06116682

Phase2, Recruiting

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

for
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Location: Billings MT, Cody WY, Bozeman MT, Great Falls MT,
Sponsor: NRG Oncology

Sex: All

Age: 45 - 70

Code: NCT05080673

Recruiting

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

for
Metastatic Malignant Neoplasm in the Liver,
Location: Billings MT, Cody WY, Bozeman MT, Great Falls MT,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05040360

Phase2, Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

for
Malignant Female Reproductive System Neoplasm,
Location: Billings MT, Bozeman MT, Great Falls MT, Anaconda MT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06126276

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,
Location: Billings MT, Bozeman MT, Great Falls MT, Anaconda MT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase2, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),
Location: Billings MT, Bozeman MT, Great Falls MT, Anaconda MT,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase3, Recruiting

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Billings MT, Sioux Falls SD, Eugene OR, Los Angeles CA,
Sponsor: Incyte Corporation

Sex: Female

Age: 18+

Code: NCT07214779

Phase3, Recruiting

Diagnosing Epilepsy To EffeCT Change

for
Epilepsy, Epilepsy (Treatment Refractory)
Location: Billings MT, Minneapolis MN, Rochester MN, Phoenix AZ,
Sponsor: Epiminder America, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07110337

Recruiting

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

for
Cystic Fibrosis
Location: Billings MT, Salt Lake City UT, Boise ID, Spokane WA,
Sponsor: Nicole Hamblett

Sex: All

Age: 12+

Code: NCT06504589

Recruiting

Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia

for
Staphylococcus Aureus Bacteremia
Location: Billings MT, Miles City MT, Butte MT, Ogden UT,
Sponsor: Intermountain Health Care, Inc.

Sex: All

Age: 18+

Code: NCT07376889

Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Billings MT, Salt Lake City UT, Omaha NE,
Sponsor: Incyte Corporation

Sex: Female

Age: 18 - 70+

Code: NCT07023627

Phase2, Recruiting

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

for
Early Breast Cancer
Location: Billings MT, Denver CO, Kennewick WA, Sioux Falls SD,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT05827081

Phase3, Recruiting

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

for
Cervical Cancer
Location: Billings MT, Denver CO, Portland OR, Maple Grove MN,
Sponsor: Pfizer

Sex: Female

Age: 18+

Code: NCT06952660

Recruiting

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

for
Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung,
Location: Billings MT, Wheat Ridge CO, Golden CO,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06758401

Phase3, Recruiting

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for
Epithelial Ovarian Cancer
Location: Billings MT, Seattle WA, Portland OR, Omaha NE,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07218809

Phase3, Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Billings MT, Regina, Salt Lake City UT, Spokane WA,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase3, Recruiting

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for
Multiple Myeloma, Newly Diagnosed Multiple Myeloma
Location: Billings MT, Aurora CO, Puyallup WA, Phoenix AZ,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06679101

Phase3, Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Billings MT, Boise ID, Spokane WA, Golden CO, Denver CO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

for
Non-Small Cell Lung Cancer
Location: Billings MT, Regina, Loveland CO, Spokane WA,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT05899608

Phase3, Recruiting